Core Laboratories N.V.
CLB | NYSE
$8.93
-$0.72 (-7.46%)
At close: Nov 5, 2026, 4:00 PM ET
$8.93
$0.00 (0.00%)
After-hours:
Nov 5, 2026, 4:01 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 526.52M | 523.85M | 509.79M | 489.74M | 470.25M | 487.27M |
Cost of Revenue | 432.24M | 435.48M | 415.74M | 410.82M | 386.41M | 385.14M |
Gross Profit | 94.28M | 88.37M | 94.05M | 78.92M | 83.84M | 102.13M |
Operating Income | 50.49M | 58.56M | 54.64M | 41.52M | 45.26M | -76.81M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 45.9M | 46.19M | 41.21M | 29.95M | 36.11M | -91.18M |
Net Income | 29.67M | 31.4M | 36.68M | 19.45M | 19.73M | -97.64M |
Selling & General & Admin | 44.23M | 38.59M | 38.89M | 38.12M | 44.17M | 32.53M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | -429K | -8.78M | 515K | -722K | -5.6M | 146.4M |
Operating Expenses | 43.8M | 29.82M | 39.41M | 37.4M | 38.58M | 178.93M |
Interest Expense | 10.57M | 12.37M | 13.43M | 11.57M | 9.15M | 14.37M |
Selling & Marketing Expenses | n/a | n/a | -1.37M | n/a | n/a | -1.5M |
Cost & Expenses | 476.03M | 465.29M | 455.15M | 448.21M | 424.99M | 564.07M |
Income Tax Expense | 15.51M | 14.03M | 4.19M | 10.3M | 15.89M | 5.9M |
Shares Outstanding (Basic) | 46.5M | 46.9M | 46.68M | 46.33M | 46.01M | 44.48M |
Shares Outstanding (Diluted) | 46.5M | 47.69M | 47.52M | 46.81M | 46.69M | 44.97M |
EPS (Basic) | 0.68 | 0.67 | 0.79 | 0.42 | 0.43 | -2.18 |
EPS (Diluted) | 0.68 | 0.66 | 0.77 | 0.42 | 0.42 | -2.16 |
EBITDA | 71.12M | 73.51M | 70.42M | 58.69M | 63.78M | 70.49M |
EBIT | 56.47M | 58.56M | 54.64M | 41.52M | 45.26M | 49.63M |
Depreciation & Amortization | 14.65M | 14.95M | 15.78M | 17.16M | 18.52M | 20.87M |
Add to Watchlist
Select watchlists to add or remove CLB